NEWSROOM

A Look Into Eaze's $35M Equity Raise, Move Into Branded Cannabis Products

US dials up coronavirus response, BIO taps Vir's George Scangos to head committee coordinating Indus

Karyopharm spotlights PhIII results after controversial FDA approval

BD News and Analysis for Biotech and Pharma

Eaze To Announce $35 Million Equity Raise Completion, Launch Of Its Own Brands

The top 100 biopharma venture investors at the megabillions deal table

Warren Buffett’s Berkshire Hathaway settles on its first biotech investment

Planet MicroCap Showcase 2020

Coronavirus: Wuhan to Round Up the Infected for Mass Quarantine Camps

MedMen Announces Leadership Change

Insys founder Kapoor gets 5.5 years in prison for role in Subsys kickback scheme

Ipsen's $1B bet on the ropes after interim phase 3 analysis

Katan Associates Getting it Done at JPM!!!

Ameri Holdings to Merge with Jay Pharma Inc., Evidence-Based Cannabinoid Medicine & Wellness Company

Katan Associates Wins Life Sciences Strategic Consulting Firm Award

2019 Year in Review

QuickBox Fulfillment Announces Growth Investment by Pike Street Capital

Big Win for Denver, Colorado Company QuickBox Fulfillment Listed on America’s Fastest-Growing Privat

You can now minor in weed.

GW Pharma's cannabis-based medicine to be tested in dementia